FIBROGEN INC Supply Agreements

19 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 4 to Master Supply Agreement between FibroGen, Inc. and STA Pharmaceutical Entities
Supply Agreements
FIBROGEN INC
Biotechnology
2022
Amendment No. 3 to Master Supply Agreement between FibroGen, Inc. and STA Pharmaceutical Entities
Supply Agreements
FIBROGEN INC
Biotechnology
2021
Astellas EU Supply Agreement between FibroGen, Inc. and Astellas Pharma Europe Ltd (Effective January 1, 2021)
Supply Agreements
FIBROGEN INC
Biotechnology
2021
Amendment No. 1 to Master Supply Agreement between FibroGen, Inc. and STA Pharmaceutical Entities
Supply Agreements
FIBROGEN INC
Biotechnology
2020
Commercial Supply Agreement between FibroGen, Inc. and Catalent Pharma Solutions, LLC for Roxadustat
Supply Agreements
FIBROGEN INC
Biotechnology
2020
API Batch Transfer Price Agreement between FibroGen, Inc. and Astellas Pharma, Inc. (June 15, 2018)
Supply Agreements
FIBROGEN INC
Biotechnology
2018
Amendment No. 31 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2017
Amendment No. 29 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2017
Amendment No. 28 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 27 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 26 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 24 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 21 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Twentieth Amendment to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Amendment No. 19 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Amendment No. 18 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Seventeenth Amendment to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Amendment No. 16 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Amendment No. 15 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015